Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × rucaparib × 1 year × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of the Oesophagus 1 Adenocarcinoma of Lung 1 ATM Gene Mutation 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡